新建福地生物科技股份有限公司可行性研究报告

Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF一、公司资料1.1基本资料本公司为拟筹建的股份有限公司，是以福地科技股份有限公司、福地科技总公司为主要发起人，联合王福生先生以及其他投资机构共同发起设立“福地生物科技股份有限公司”，注册资本将为1250万元。其中，福地科技股份有限公司和福地科技总公司主要以现金出资，王福生先生以无形资产折价入股，其他投资机构以现金出资。1.2经营范围公司拟进行CIK细胞、DC疫苗、IPC和NKT细胞治疗药物的研制和临床试用以及清毒保肿中药复方制剂等项目的开发。Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF1.3组织架构股东会福地生物科技股份有限公司（筹）福地总公司王福生其它股东福地科技董事会总经理1.5股东及合作伙伴1、王福生先生解放军３０２医院生物工程研究室（又叫作解放军传染病研究所生物工程研究室），是最近两年发展起来的研究机构，研究室由一名教授、两名副教授、四名助理研究员、五名在读博士生、七名毕业研究生和技术人员组成。研究室由中科院院士、解放军军事医学院Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF吴祖泽教授及解放军第302医院陈菊梅主任医师、教授担任技术指导。研究室主任王福生教授为解放军302医院传染病研究所常务副所长，博士生导师。曾先后负责并参与国外和中国国家自然科学基金等资助的多项课题。在国内外发表科研论文８０余篇。在肝病、肿瘤生产治疗方面具有较市造诣，研究室先后承担了国家自然科学基金资助的课题２项，军队九五攻关课题１项，国内、国际使合作课题３项，院内创新课题１项。目前，研究室在肝炎、肝癌生产治疗技术方面具有国际先进水平。2、广东福地科技总公司广东福地科技总公司成立于一九八八年，是东莞市政府直属的全民所有制企业，注册资本39,800万元人民币，主营业务有彩管及其零部件制造、酒店、计算机软硬件等。截止2000年12月31日，公司总资产为1,059,187,552元，净资产998,087,992元，员工300人。由其出资全资控股企业有：东莞市广彩城酒店、东莞市福地电子化工材料有限公司、东莞市福地实业发展有限公司。3、广东福地科技股份有限公司广东福地科技股份有限公司为在深圳证券交易所公开交易的上市公司（简称“福地科技”，代码“0828”），截止2000年6月30日Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF公司总股本9.7057亿股，总资产为40亿元，净资产为30亿元。是国家重点扶持的520家大企业、广东省重点发展83家大集团企业，广东省高新技术企业和广东省50家龙头工业企业之一。4、其他公司二、行业概览现代生物技术（生物工程）是指对生物有机体在分子、细胞或个体水平上通过一定的技术手段进行设计操作、为达到目的或需要，以改良物种品质和生命大分子特性或生产特殊用途的生命大分子物质技术。生物技术的发展将为解决人类面临的重大健康问题开辟广阔的前景，生物技术与计算机微电子技术、新能源等同列为高科技，被视为是二十一世纪科学技术的核心。生物医药行业作为生物技术的最活跃的应用领域之一，被誉为是“永远的朝阳产业”，它具有高技术、高投入、高附加值等特点，具有良好的成长性。生物医药是医药行业发展的新方向，从国外生物医药市场发展的最新进展来看，基因治疗是其突出的表现之一，为此，许多国家相续投入大量资金、人力进行生物基因工程研究。我国在产业政策（如国家“８６３”Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF　计划）上也给予了大力支持，促使了这一行业的迅速发展。国产生物药品正陆续上市，正逐步成为我国企业在世界范围内具有较强竞争能力的行业之一。新的世纪，生物制药行业也将迎来新的发展机会。肝炎是我国最常见的病毒性传染病，其人群感染率为58%，全国约有1.3亿乙肝病毒携带者。由于目前尚无特效的治疗方法，因此，探索细胞治疗、基因治疗等生物治疗方案遂成为生物制药研究的焦点。解放军302医院生物工程研究所开展的“抗慢性肝炎和肝癌的CIK细胞、DC疫苗的研制和临床应用以及肝癌基因治疗”等项目研究正顺应基因工程发展的这一潮流。CIK（Cytokine-inducedkiller）是近年发现的一种新型、高效、具有广谱杀瘤活性的免疫活性细胞，CIK输入患者体内后，能够大大提高机体的免疫功能，在治疗早期肝癌及根除肝癌手术后的复发方面具有良好的治疗作用；在治疗慢性肝炎方面，可促进肝功能的恢复，使肝炎患者的e抗原转阴，有助于机体清除肝炎病毒，且副作用较小，在临床上具有良好的应用前景。DC疫苗是一种具有治疗作用的抗肝炎病毒的疫苗，能有效地打破机体的免疫耐受和触发抗病毒CTL反应，有望在清除慢性乙型病毒的治疗、阻断肝纤维化、肝硬化和肝癌的发展过程中发挥重要的作用。该项目的治疗方案具有安全性、有效性和特异性，结合了当今基因治疗和细胞治疗等生物高技术，为广大肝病患者提供了新的治疗途径，具有极强的社会效益和经济效益，应用前景非常广阔。Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF三、公司技术公司技术主要发明者王福生先生运用该技术研究开发的“抗慢性肝炎和肝癌的ＣＩＫ细胞、ＤＣ疫苗”技术产品及后续项目产品如“清毒保肝中药复方剂”等，此项研究在国内外尚处于领先水平。同时，王福生先生领导的解放军302生物工程研究室由中科院院士、解放军军事医学科学院吴祖泽教授担任指导，该研究室拥有一批在肝病、肿瘤生物治疗、基因工程研究方面经验丰富的专家，先后承担了多项国家自然科学基金资助项目，军队九五攻关项目及国内外合作项目。同时，解放军302生物工程研究室与美国、日本等医学院建立了合作关系，随时跟踪国际生物制药研究的最新动向，确保研究室项目的领先性。四、公司产品4.1主要产品公司主要产品有：uCIK（Cytokine-inducedkiller）细胞；u抗慢性肝炎的DC疫苗；u治疗肝炎、肿瘤的IPC、NKT等细胞治疗药；Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahFu清毒保肝中药复方制剂等。4.2产品功能及用途１、CIK细胞CIK细胞是治疗早期肝癌及根除肝癌复发的一种免疫活性细胞。它有助于提高机体的免疫功能，促进肝功能的恢复，促使肝炎患者的e抗原转阴，有助于清除肝炎病毒，在临床上具有良好的应用前景。２、DC疫苗DC疫苗是具有治疗功效的抗肝炎病毒疫苗，能有效地打破机体的免疫耐受和触发抗病毒CTL反应，对清除慢性乙型肝炎、阻断肝纤维化、肝硬化和肝癌具有重要作用。３、清毒保肝中药复方制剂清毒保肝中药复方制剂，具有清除体内有毒代谢成分、保护肝脏的功能，促进机体热量代谢和减肥的功效。五、市场分析Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF5.1市场现状病毒性肝炎、肝癌是严重危害人们生命和健康的一种常见传染性疾病，在我国就具有１亿多的慢性肝炎、肝癌病人和病毒携带者，有很大的市场需求；至今为止，国际上尚没有研制出特效药，因此，CIK细胞、DC疫苗具有广阔的市场前景。目前全球约有1500亿美元的药品市场，但生物药品市场份额很小，1996年仅为127亿美元，1997年约146美元，2000年约为200亿美元左右。随着生物工程的深入开发，基因工程逐渐纳入各国高技术发展领域，在政策上给予大量的支持（如我国的“863”计划），因此，众多公司看好未来的生物药品市场，经过近几年的重组与投资，涉足生物医药的上市公司正逐步增加，生物技术板块正进入既有业绩支撑，又有“热点概念”的快速发展阶段，吸引着许多公司开始进入生物制药行业。5.2市场需求CIKSelection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF细胞、DC疫苗采用细胞、基因方法治疗肝炎、肝癌，具有安全性、有效性和特异性等特点，是一种新型的肝病治疗途径，具有生物工程、基因概念，符合现代技术发展趋势，迎合了现代人追求高科技产品的心理。随着人们生活水平的逐步提高，对健康的追求与关注与日俱增，对药品的技术含量、治疗方法也越来越关注，加之我国1亿多肝炎病患者市场，从而形成了对肝炎、肝癌治疗药品的巨大市场需求。六、营销策略6.1销售理念公司将充分利用广东福地集团形成的销售网络，利用上市公司福地科技的良好社会形象，迅速扩大产品的市场占有率。利用解放军302医院在学术研究领域的声望及与军队、医院的良好合作关系，形成产品协作关系。遵循“长期多赢，共同发展”的原则建立稳定的产品使用与服务渠道，建立忠诚的药品代理网络。引入企业CI形象设计，突出产品的基因与细胞治疗理念，创立中国基因、生物制药领域的名牌。公司发展成为跨行业、跨地域、多元化的具有国际竞争力的大型企业集团。6.2销售对象u各级医院u药品代理商七、竟争情况Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF7.1竟争对手１、国际竞争对手CIK细胞、DC疫苗是治疗肝炎、肝部癌的新型生物药品，具有基因、细胞治疗的高科技含量，技术水平较高，基因、细胞治疗药品在未来的国际、国内市场将处于主导地位。由于国外在基因、细胞方面的研究早于国内，相对比较成熟，公司的主要竞争对手将来自国外，在中国加入WTO后，国外药品对国内药品的影响也将会增大。２、国内竞争对手受国外基因工程研究及国家产业发展政策的影响，国内基因研究发展迅速，而肝炎、肝癌类制药的巨大市场潜力吸引着众多的研究机构与企业从事相关产品的开发与研制工作，这些都是公司的潜在竞争者。7.2本公司竟争优势１、设备优势公司产品开发研究的主要设备：流式细胞仪、采血机、大型血液低温离心机、CO2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF培养箱、程序式细胞冻存仪等均从国外进口，技术先进，科技含量高，在国内处于领先地位。１、技术优势公司技术支持是解放军302医院生物工程研究所，研究室成员均是行业研究方面的专家，由中科院院士、解放军302医院吴祖泽教授及解放军第302医院陈菊梅主任医师、教授担任技术指导，研究室在肝炎、肝癌生物治疗技术方面具有国际先进水平。公司主要项目CIK细胞、DC疫苗采用先进的细胞、基因治疗方法，是预防、治疗肝炎、肝癌的新途径，在国内外处于领先水平。而且研究所与国内外建立了广泛的合作与协作关系；如美国的MountSinai医学院、ScrippsRes.Int.、NCI免疫调节研究室；日本的Eheime大学医学院。２、管理优势公司主要合作伙伴之一解放军Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF302医院生物工程研究所具有人民军队踏实勤奋，勇于创新，团结协作、竞争进取，技术熟练、争创一流的优良作风与品格，将为公司形成良好风范打下基础。合作伙伴广东福地是东莞最大的国有企业，福地科技是其上市子公司，具有良好的社会形象，福地公司在经济效益、科技水平、产品开发上在全国广东省同行中名列前茅；福地总公司坚持“引进、消化、吸收、创新、振兴民族工业”的发展方针，公司先后创建了广东福地科技股份有限公司，广东福地日合偏光器件有限公司，国际三星级标准的“广彩城”酒店，东莞市卓越贸易公司，东莞市卓越电脑公司，东莞市福地电子材料有限公司，东莞市福地纯水有限公司等一批子公司，使该公司不断发展壮大，逐步发展成为跨行业、跨地域、多元化的具有国际竞争力的大型企业集团，它形成了系统的管理体系，具有成熟的管理方法，将为新公司未来的发展提供强有力的支持。１、政策优势及其它（1）、肝炎、肝癌病毒治疗药品研究符合广大人民的利益，其成果具有良好的社会效益，能得到社会的广泛支持与欢迎。（2）、基因工程、生物制药是国家鼓励与支持的行业，具有国家产业政策的支持。（3）、广东福地公司作为广东省的著名企业，得到了当地政府与中央领导的关注，国家领导人李鹏、吴邦国、尉建行等曾先后到福地公司视察指导工作。八、风险因素及对策8.1风险因素1、技术风险Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF本公司产品目前技术水平优于国外公司，在国际上处于领先地位。但是，目前，国内、国际其他科研机构也在对该类技术进行研究和开发，一旦有效用更好的技术或可替代本技术的更先进的产品产生，本公司的技术和产品将面临严峻的竞争，同时，本公司的主要产品主要依托于解放军302医院生物工程研究室，技术依赖的集中度相对较高。2、技术剽窃风险本公司产品的治疗作用处于国际领先水平，在国内基本上不存在明显的竞争对手，预计能为公司带来丰厚的收益，因此在技术上存在被他人剽窃的风险。虽然本公司会制定相应的制度加以限制，但此风险若有发生，公司必将牵扯大量的人力、物力，影响公司的盈利水平。3、市场竞争风险Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF公司主要产品在我国尚处于新生代位置，预计将凭借其优越的价格性能比，将在相当长的一段时间内占有一定的市场份额，但国外公司的同类产品和国内其他厂家可能生产出来的可替代产品预计将会不断出现，因此公司现有产品存在着较大的市场竞争风险。8.2风险对策1、技术风险对策本公司技术的主要依托方解放军302医院生物工程研究院在肝炎、肝癌生物治疗技术方面具有国际先进水平，使公司拥有强大的技术支持，同时开发新技术、新产品，使公司能够始终处于国内外生物活性工程领域的先进行列，同时，通过，解放军302医院生物工程研究院与本公司形成的紧密型合作关系，将有效的解决技术集中风险问题。2、技术剽窃风险对策本公司所使用的技术只限于本公司使用，不对外出售或披露，尽量降低他人剽窃的风险。本公司制定有严格的保密制度，单位内任何人泄漏商业秘密，都将被追究法律责任。3、市场竞争风险对策Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF本公司将充实和培育高素质的销售队伍，同时采用技术培训推销产品的方式，使公司在国内外拥有强大的销售网络。另外，公司将不断开发新技术、新产品，增强市场竞争能力，扩大利润来源。九、未来发展计划１、公司将以CIK细胞、DC疫苗作为主要产品，在获取正式批准应用文号后，进行产品批量生产，利用产品的高技术优势，扩大生产规模，迅速占领肝炎、肝部癌治疗药品市场，在获得良好社会效益的同时，取得利润的最大化，实现良好的经济效益。２、加强研究开发力度，开发系列新产品。公司将以解放军302医院生物工程研究室为基础，根据市场对产品需求，开发出治疗、预防肝炎、肝癌的系列基因生物制药品种。进一步探讨治疗肝炎等疾病的新途径，并尽快把研究开发的生物药品推向市场。３、完善公司治理结构。公司将以现代企业的标准来实施管理，建立产权清晰、权责明确的科学管理制度，形成研究开发、产品生产、市场推广的体系，按照市场原则，加速研究产品的商品化、市场化，创造生物制药领域的名牌企业。４、公司在正式运营后，拟谋求在国内二板市场上市。Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF十一．资金需求与使用计划11.1资金筹措拟成立股份有限公司运作该项目，股份公司由广东福地科技总公司、福地科技股份有限公司、王福生先生和新投资方共同发起设立，预计注册资本为1250万元。其中，福地科技总公司投资125万元，占总股本的10%；福地科技股份有限公司投资437.5万元，占总股本的35%；王福生先生以自有技术作价187.5万元折股，占总股本的15%；其余两家股东各投资250万元，分别占总股本的20%。项目资金运用主要用于两个阶段：即“CIK细胞、DC疫苗“的研究开发和临床应用阶段与批量生产阶段。整个项目预计需投入自有资金总额为1000万元左右，分两阶段投入。11.2资金使用计划1资金主要用于以下四个方面a大型设备及技术投入b新增仪器设备及相关试验用配套药品c建造科研场所、办公场所、厂房等建筑物Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahFd项目推广或技术转让所需资金1资金使用情况明细表使用项目使用金额（万元）a大型设备及技术490其中：流式细胞仪63采血机48大型血液低温离心机20CO2培养箱4程式细胞冻存仪16技术等无形资产339b建造科研、办公所、厂房等建筑物400c新增仪器设备、相关试验用配套药品10d项目推广或技术转让所需资金1002投资规划和资金筹措表单位：万元序号项目合计建设起点建设期投产期达产期Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF1投资总额11081.1建设投资10004902102001001.2流动资金1088820小计4902102881202资金筹措11002.1自有资金投入10002.2借款10888202.2.1长期借款利息借款8082.2.2短期借款202.3其它Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF十二、盈利及现金流量预测12.1基本假设在对此股份制企业项目进行经济分析时采纳以下假设：●所遵循的现行国家政策、法律法规具有动态一致性●在整个项目开发、推广过程中技术人员充裕●项目在其前十年（包括研发期）期间技术优势继续保持，市场无更先进的替代品。●有充足的营运资金，销售收入按时收回或无三年以上的应收款项●按国家要求已把利率、汇率和物价上涨率等变动因素均考虑进去，打足投资，未留缺口。●所得税率按30％计算，固定资产投资方向调节税按国家行业规定取0，其它税收均不考虑。●保持正常的存货周转率。●无其它人为不可抗力因素及不可预见因素造成的重大不利影响。12.2备选方案Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF方案A：设计生产能力为年产CIK细胞注射液30万支，单价30元。DC疫苗20万支，单价20元。研究开发期（即建设期）两年（2000年始），第三年为投产期，生产负荷为60％，第四至第十年为正常生产期（即达产期），生产负荷为100％。方案B：投产期末项目全部转让或成功上市，此方案符合原始资料中的开发项目总体目标。12.1盈利及现金流量预测说明（方案A）1单位产品平均收入、成本及利润预测说明产品名称项目CIK细胞注射液(单位：元/支)DC疫苗(单位：元/支)1、单位产品销售收入30202、单位产品总成本22.9414.24其中：原材料64　动力、物料消耗2.11.4　工资、福利105Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF　　　修理费0.390.39　　　折旧费1.111.11　　　摊销费0.690.69　　　利息支付0.160.16其它费用1.70.85税金支付0.780.643、单位产品税后利润7.15.761各年度产量、收入、成本及利润总额预测说明由原始资料数据及推算可知：全国有1.3亿乙肝病毒携带者，假设有1亿患者不能自身产生抗体，3000万人应该治疗，1000万人同意治疗,300万人同意使用本药品，平均每年使用2支，即每年需求量为600万支。其中CIK细胞注射液300万支，DC疫苗300万支。所以，年产50万支并全部售出，只占了市场份额的10％左右，生产规模可进一步扩大。CIK细胞注射液Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF项目年度生产负荷产量（万支）销售收入（万元）总成本（万元）税后利润（万元）2002年60％185404131272003年100％30900688212DC疫苗项目年度生产负荷产量（万支）销售收入（万元）总成本（万元）税后利润（万元）2002年60％12240171692003年100％20400285115··················2009年100％2040028511512．4盈利及现金流量预测表（方案A）盈利预测表单位：万元年度20022003200420052006…2009Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF项目销售收入7801300130013001300…1300总成本584973973973973…973税后利润196327327327327…327提取法定公积金19.632.732.732.732.7…32.7提取法定公益金9.816.3516.3516.3516.35…16.35可分配利润166.6278278278278…278实分配利润166.6278278278264…264甲方利润83.3139139139132…132乙方利润81.6136.2136.2136.2129.4…129.4丙方利润0.831.391.391.391.32…1.32丁方利润0.831.391.391.391.32…1.32未分配利润000014…14累计未分配利润000014…56提取法定公积金10％，提取法定公益金5％，从2006年开始在可分配利润中提取5％的任意公积金。Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF现金流量预测表年度项目2000200120022003200420052006…2009一、现金流入7801300130013001300…1408销售收入7801300130013001300…1300回收流动资金…108二、现金流出545.5265.5826.31054933.9933.9933.9…933.9建设投资490210200100…流动资金8820…经营成本55.555.5506.8881.3881.3881.3881.3…881.3提取法定公益金9.816.3516.3516.3516.35…16.35所得税21.736.236.236.236.2…36.2三、净现金流量-545-265-46246.2366.2366.2366.2…474Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF四、累计净现金流-545-810-856-610-244122488.2…1694注：1、本财务指标预算是保持现有资金投入量不变的情况下的静态计算，没有考虑诸如资金追加投资（如上市、增资扩股、或借贷等）。2、22000年、2001年：经营成本＝当年折旧费3、2002年－2009年：经营成本＝总成本－折旧费－所得税4、2002年为投产期，生产负荷为60％5、2006年－2008年除累计净现金流量外其它指标均相同12.1方案B盈利预测说明如果企业投产期末（2003年末）在二板成功上市，根据最新资料表明，平均每股投资价格为2元左右。以主板市场高科技股票平均上市开盘价为计算依据，2000年，高科技类上市当天的平均价格为30元左右，这样增值率为15倍。从上述分析可以计算出投资收益。在投资1000万的情况下，上市后则有：1000万×20％×15＝3000万，（其中平均上市率为20％）所以三年为回报周期，投资收益率为（3000万－1000万）／3000万＝66.7%,也就是说，保守估计，平均每年的静态投资收益率为将高达66.7%Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF,按平均投资利税率30％计算，则平均每年税后利润率为36.7%.如果项目在投产期末一次性成功转让，也可参照上述方法测算投资收益率及税后利润率。Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormSelection.ParagraphFormaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2Selection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPointselection.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFormat.LineSpacingLinesToPoction.ParagraphFormat.LineSpacingLinesToPoints(2)Selection.ParagraphFaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahF